ストックスクリーナーアプリを入手
111.38
1.79%
-2.03
アフターアワーズ：
111.37
-0.010
-0.01%
前日終値:
$113.41
開ける：
$113.9
24時間の取引高:
9.97M
Relative Volume:
1.03
時価総額：
$275.09B
収益：
$65.51B
当期純損益:
$8.93B
株価収益率:
31.35
EPS:
3.5532
ネットキャッシュフロー:
$14.12B
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-5.53%
6か月 パフォーマンス:
+19.87%
1年 パフォーマンス:
+48.90%
1日の値動き範囲:
$110.94
$113.93
1週間の範囲:
$110.94
$114.06
52週間の値動き範囲:
$74.37
$125.14
Merck Co Inc Stock (MRK) Company Profile
Compare MRK vs LLY, JNJ, ABBV, NVS, AZN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
111.38 | 280.10B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,004.92 | 897.72B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
226.71 | 555.59B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
210.39 | 372.39B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
148.08 | 285.77B | 54.66B | 13.58B | 16.05B | 7.0171 |
AZN
Astrazeneca Plc
|
181.58 | 286.84B | 60.48B | 10.40B | 8.05B | 3.3297 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-02-20 | 開始されました | Barclays | Overweight |
| 2026-02-13 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-10-13 | 再開されました | Citigroup | Neutral |
| 2025-09-17 | ダウングレード | Berenberg | Buy → Hold |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Neutral |
| 2025-02-18 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-02-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-08 | ダウングレード | Truist | Buy → Hold |
| 2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-12-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-11 | ダウングレード | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-03-11 | ダウングレード | Societe Generale | Hold → Sell |
| 2024-01-04 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-27 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | アップグレード | UBS | Neutral → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Hold |
| 2023-04-13 | アップグレード | Citigroup | Neutral → Buy |
| 2023-03-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-03-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 開始されました | Jefferies | Buy |
| 2023-02-22 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-10-10 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-14 | アップグレード | Berenberg | Hold → Buy |
| 2022-07-06 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 再開されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 開始されました | Goldman | Buy |
| 2021-12-16 | 開始されました | Daiwa Securities | Neutral |
| 2021-12-13 | ダウングレード | UBS | Buy → Neutral |
| 2021-12-09 | 開始されました | Wells Fargo | Overweight |
| 2021-12-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-11-29 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-11-01 | アップグレード | Argus | Hold → Buy |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-05-20 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-08-03 | アップグレード | Goldman | Neutral → Buy |
| 2020-06-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-16 | 開始されました | SVB Leerink | Outperform |
| 2019-07-03 | 開始されました | Mizuho | Buy |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-05-13 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 繰り返されました | Citigroup | Buy |
| 2018-10-09 | 再開されました | Guggenheim | Buy |
| 2018-04-23 | アップグレード | Goldman | Neutral → Buy |
| 2018-04-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-03-12 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-07 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2018-01-16 | アップグレード | SunTrust | Hold → Buy |
すべてを表示
Merck Co Inc (MRK) 最新ニュース
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck & Co. Inc. stock (US58933Y1055): Key cancer franchise drives fresh earnings spotlight - AD HOC NEWS
Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report - Benzinga
Merck & Co., Inc. stock (US58933Y1055): pharma giant doubles down on M&A as investors eye post-Keytr - AD HOC NEWS
Merck & Co., Inc. $MRK Stock Holdings Increased by Phoenix Financial Ltd. - MarketBeat
Merck & Co., Inc. $MRK is Conning Inc.'s 5th Largest Position - MarketBeat
Bessemer Group Inc. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Allworth Financial LP Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
World Investment Advisors Buys 20,067 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rayburn West Financial Services LLC Takes $1.17 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Summit Wealth Group LLC Co. Has $522,000 Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Buys 100,280 Shares of Merck & Co., Inc. $MRK - MarketBeat
Top Companies in Hospital Acquired Infection Treatment MarketMerck & Co Inc, Pfizer Inc, Cipla Ltd etc. - openPR.com
Merck & Co. Inc. stock (US58933Y1055): Q1 results show revenue growth amid Keytruda strength - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Q1 beat and upgraded 2026 guidance drive 8% jump - AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Q1 earnings beat with revenue growth - AD HOC NEWS
Merck's (NYSE:MRK) Soft Earnings Are Actually Better Than They Appear - Moomoo
VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Lifted by Independent Advisor Alliance - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Money Concepts Capital Corp - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Analyst Reinstates Merck (MRK) with ‘Neutral’ Rating, $125 Price Target - Insider Monkey
Merck & Co. stock (US58933Y1055): Oncology portfolio advances at ASCO 2026 - AD HOC NEWS
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex - Zacks Investment Research
Merck (MRK) Tops Quarterly Sales Forecasts as Keytruda Drives Growth - Insider Monkey
Top Research Reports for UnitedHealth, Merck & Qualcomm - Yahoo Finance Singapore
Merck stock (US58933Y1055): Q1 earnings beat, revenue guidance narrowed - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Q1 earnings beat with revenue growth - AD HOC NEWS
Merck & Co., Inc. $MRK Shares Sold by SVB Wealth LLC - MarketBeat
Swiss Life Asset Management Ltd Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) - The Manila Times
Investors Can Find Comfort In Merck's (NYSE:MRK) Earnings Quality - Yahoo Finance Singapore
Securian Asset Management Inc. Has $7.10 Million Position in Merck & Co., Inc. $MRK - MarketBeat
NewEdge Wealth LLC Has $9.33 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ABN AMRO Bank N.V. - MarketBeat
Osprey Private Wealth LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Applied Finance Dividend Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Bryn Mawr Trust Advisors LLC Has $24.27 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck 1Q Januvia/Janumet Sales $574M >MRK - Moomoo
Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWS
Wesbanco Bank Inc. Sells 17,179 Shares of Merck & Co., Inc. $MRK - MarketBeat
Manning & Napier Advisors LLC Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Lighthouse Financial Services Inc. ADV Invests $1.02 Million in Merck & Co., Inc. $MRK - MarketBeat
The Covered Bridge Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Crossmark Global Holdings Inc. Has $24.83 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Ethic Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. (NYSE:MRK): A High Dividend Rating Backed by Strong Profitability and Financial Health - ChartMill
Merck Co Inc (MRK) 財務データ
収益
当期純利益
現金流量
EPS
1.83%
大文字化:
|
ボリューム (24 時間):